REGENACY PHARMACEUTICALS, LLC

Organization

BOSTON, MA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
HDAC1,2 inhibitors
- Patent number 11,858,919
- Issue date Jan 2, 2024
- REGENACY PHARMACEUTICALS, INC.
- John H. Van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine derivatives as HDAC1/2 inhibitors
- Patent number 11,702,389
- Issue date Jul 18, 2023
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted piperazines as selective HDAC1,2 inhibitors
- Patent number 11,542,242
- Issue date Jan 3, 2023
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Histone deacetylase 6 selective inhibitors for the treatment of cis...
- Patent number 11,013,740
- Issue date May 25, 2021
- REGENACY PHARMACEUTICALS, LLC
- Annemieke Kavelaars
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperidine derivatives as HDAC1/2 inhibitors
- Patent number 10,968,180
- Issue date Apr 6, 2021
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HDAC inhibitors for the treatment of diabetic peripheral neuropathy
- Patent number 10,858,323
- Issue date Dec 8, 2020
- REGENACY PHARMACEUTICALS, LLC
- Olga Golonzhka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted piperazines as selective HDAC1,2 inhibitors
- Patent number 10,774,056
- Issue date Sep 15, 2020
- REGENACY PHARMACEUTICALS, INC.
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted piperazines as selective HDAC1,2 inhibitors
- Patent number 10,385,031
- Issue date Aug 20, 2019
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine derivatives as HDAC1/2 inhibitors
- Patent number 10,358,421
- Issue date Jul 23, 2019
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Histone deacetylase 6 selective inhibitors for the treatment of cis...
- Patent number 10,272,084
- Issue date Apr 30, 2019
- REGENACY PHARMACEUTICALS, LLC
- Annemieke Kavelaars
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperidine derivatives as HDAC1/2 inhibitors
- Patent number 10,239,837
- Issue date Mar 26, 2019
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective HDAC3 inhibitors
- Patent number 10,125,131
- Issue date Nov 13, 2018
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HDAC inhibitors for the treatment of diabetic peripheral neuropathy
- Patent number 10,040,769
- Issue date Aug 7, 2018
- REGENACY PHARMACEUTICALS, LLC
- Olga Golonzhka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective HDAC1 and HDAC2 inhibitors
- Patent number 9,957,259
- Issue date May 1, 2018
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperidine derivatives as HDAC1/2 inhibitors
- Patent number 9,790,180
- Issue date Oct 17, 2017
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective HDAC1 and HDAC2 inhibitors
- Patent number 9,765,066
- Issue date Sep 19, 2017
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PIPERIDINE DERIVATIVES AS HDAC1/2 INHIBITORS
- Publication number 20230348389
- Publication date Nov 2, 2023
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PIPERAZINES AS SELECTIVE HDAC1,2 INHIBITORS
- Publication number 20220281833
- Publication date Sep 8, 2022
- REGENACY PHARMACEUTICALS, INC.
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HDAC1,2 Inhibitors
- Publication number 20220033388
- Publication date Feb 3, 2022
- REGENACY PHARMACEUTICALS, LLC
- John H. VAN DUZER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINE AND PYRAZINE HDAC1,2 INHIBITORS
- Publication number 20210332036
- Publication date Oct 28, 2021
- REGENACY PHARMACEUTICALS, LLC
- John H. VAN DUZER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Histone Deacetylase 6 Selective Inhibitors for the Treatment of Cis...
- Publication number 20210251990
- Publication date Aug 19, 2021
- REGENACY PHARMACEUTICALS, LLC
- Annemieke Kavelaars
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIPERIDINE DERIVATIVES AS HDAC1/2 INHIBITORS
- Publication number 20210179559
- Publication date Jun 17, 2021
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HDAC INHIBITORS FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY
- Publication number 20210155593
- Publication date May 27, 2021
- REGENACY PHARMACEUTICALS, LLC
- Olga Golonzhka
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PIPERAZINES AS SELECTIVE HDAC1,2 INHIBITORS
- Publication number 20200377465
- Publication date Dec 3, 2020
- REGENACY PHARMACEUTICALS, INC.
- John H. van Duzer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIPERIDINE DERIVATIVES AS HDAC1/2 INHIBITORS
- Publication number 20190359569
- Publication date Nov 28, 2019
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Histone Deacetylase 6 Selective Inhibitors for the Treatment of Cis...
- Publication number 20190343834
- Publication date Nov 14, 2019
- REGENACY PHARMACEUTICALS, LLC
- Annemieke Kavelaars
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE HDAC1,2 INHIBITORS
- Publication number 20190330169
- Publication date Oct 31, 2019
- REGENACY PHARMACEUTICALS, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE HDAC1,2 INHIBITORS
- Publication number 20180141923
- Publication date May 24, 2018
- Regenacy Pharmaceuticals, LLC
- John H. van Duzer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE HDAC1 AND HDAC2 INHIBITORS
- Publication number 20180030040
- Publication date Feb 1, 2018
- Regenacy Pharmaceuticals, LLC
- John H. van Duzer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIPERIDINE DERIVATIVES AS HDAC1/2 INHIBITORS
- Publication number 20180022702
- Publication date Jan 25, 2018
- Regenacy Pharmaceuticals, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINE DERIVATIVES AS HDAC1/2 INHIBITORS
- Publication number 20170369441
- Publication date Dec 28, 2017
- Regenacy Pharmaceuticals, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HDAC1/2 INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE AND/OR CO...
- Publication number 20170240535
- Publication date Aug 24, 2017
- Regenacy Pharmaceuticals, LLC
- John H. van Duzer
- C07 - ORGANIC CHEMISTRY

REGENACY PHARMACEUTICALS, LLC

Organization

Patents Grantslast 30 patents

HDAC1,2 inhibitors

Piperidine derivatives as HDAC1/2 inhibitors

Substituted piperazines as selective HDAC1,2 inhibitors

Histone deacetylase 6 selective inhibitors for the treatment of cis...

Piperidine derivatives as HDAC1/2 inhibitors

HDAC inhibitors for the treatment of diabetic peripheral neuropathy

Substituted piperazines as selective HDAC1,2 inhibitors

Substituted piperazines as selective HDAC1,2 inhibitors

Piperidine derivatives as HDAC1/2 inhibitors

Histone deacetylase 6 selective inhibitors for the treatment of cis...

Piperidine derivatives as HDAC1/2 inhibitors

Selective HDAC3 inhibitors

HDAC inhibitors for the treatment of diabetic peripheral neuropathy

Selective HDAC1 and HDAC2 inhibitors

Piperidine derivatives as HDAC1/2 inhibitors

Selective HDAC1 and HDAC2 inhibitors

Patents Applicationslast 30 patents

PIPERIDINE DERIVATIVES AS HDAC1/2 INHIBITORS

SUBSTITUTED PIPERAZINES AS SELECTIVE HDAC1,2 INHIBITORS

HDAC1,2 Inhibitors

PYRIMIDINE AND PYRAZINE HDAC1,2 INHIBITORS

Histone Deacetylase 6 Selective Inhibitors for the Treatment of Cis...

PIPERIDINE DERIVATIVES AS HDAC1/2 INHIBITORS

HDAC INHIBITORS FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY

SUBSTITUTED PIPERAZINES AS SELECTIVE HDAC1,2 INHIBITORS

PIPERIDINE DERIVATIVES AS HDAC1/2 INHIBITORS

Histone Deacetylase 6 Selective Inhibitors for the Treatment of Cis...

SELECTIVE HDAC1,2 INHIBITORS

SELECTIVE HDAC1,2 INHIBITORS

SELECTIVE HDAC1 AND HDAC2 INHIBITORS

PIPERIDINE DERIVATIVES AS HDAC1/2 INHIBITORS

PIPERIDINE DERIVATIVES AS HDAC1/2 INHIBITORS

HDAC1/2 INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE AND/OR CO...

Trademarklast 30 trademarks